ALID Stock Overview
Allied Corp., a medical cannabis production company, engages in the research, development, and production of cannabinoid health solutions in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Allied Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.26 |
| 52 Week High | US$0.72 |
| 52 Week Low | US$0.10 |
| Beta | 0.066 |
| 1 Month Change | 32.38% |
| 3 Month Change | -23.21% |
| 1 Year Change | -61.07% |
| 3 Year Change | -73.52% |
| 5 Year Change | n/a |
| Change since IPO | -81.60% |
Recent News & Updates
Recent updates
Shareholder Returns
| ALID | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | -11.6% | 2.4% | 2.1% |
| 1Y | -61.1% | 0.2% | 2.4% |
Return vs Industry: ALID underperformed the US Pharmaceuticals industry which returned -1.4% over the past year.
Return vs Market: ALID underperformed the US Market which returned -1% over the past year.
Price Volatility
| ALID volatility | |
|---|---|
| ALID Average Weekly Movement | 36.6% |
| Pharmaceuticals Industry Average Movement | 10.6% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in US Market | 15.7% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: ALID is more volatile than 90% of US stocks over the past 3 months, typically moving +/- 37% a week.
Volatility Over Time: ALID's weekly volatility has increased from 29% to 37% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2013 | n/a | Calum Hughes | https://allied.health |
Allied Corp., a medical cannabis production company, engages in the research, development, and production of cannabinoid health solutions in the United States. It offers hemp derived CBD natural health products, including Liberty, a hemp-derived cannabidiol (CBD) tincture; Tactical Hydration, a CBD infused electrolyte replacement drink; FIZZ Tablets for adding in a water bottle; Battle Balm, a CBD roll on activity rub for aches and pains; and Quick Hit, a CBD gummies under the Tactical Relief brand. The company also provides Hydrosport CBD Drink, a CBD infused electrolyte replacement drink with sodium citrate electrolyte replacement; Hydrosport Tincture, a CBD tincture fortified with specific terpene profile; FIZZ Tablets for adding to a water bottle; Sport Rub, a CBD post activity rub for aches and pains; and Quick Hit, a CBD gummies with vitamin B12 under the Equilibrium Bio brand.
Allied Corp. Fundamentals Summary
| ALID fundamental statistics | |
|---|---|
| Market Cap | US$25.66m |
| Earnings (TTM) | -US$6.52m |
| Revenue (TTM) | US$192.67k |
133.2x
P/S Ratio-3.9x
P/E RatioIs ALID overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ALID income statement (TTM) | |
|---|---|
| Revenue | US$192.67k |
| Cost of Revenue | -US$391.32k |
| Gross Profit | US$583.98k |
| Other Expenses | US$7.10m |
| Earnings | -US$6.52m |
Last Reported Earnings
Feb 28, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.067 |
| Gross Margin | 303.11% |
| Net Profit Margin | -3,383.80% |
| Debt/Equity Ratio | -268.6% |
How did ALID perform over the long term?
See historical performance and comparison